Statistics

Total Visits

Views
Which patients benefit most from primary surgery or neoadjuvant chemotherapy in stage IIIC or IV ovarian cancer? An exploratory analysis of the European Organisation for Research and Treatment of Cancer 55971 randomised trial(legacy) 135
Which patients benefit most from primary surgery or neoadjuvant chemotherapy in stage IIIC or IV ovarian cancer? An exploratory analysis of the European Organisation for Research and Treatment of Cancer 55971 randomised trial(legacy) 69

Total Visits per Month

December 2023 January 2024 February 2024 March 2024 April 2024 May 2024 June 2024
Which patients benefit most from primary surgery or neoadjuvant chemotherapy in stage IIIC or IV ovarian cancer? An exploratory analysis of the European Organisation for Research and Treatment of Cancer 55971 randomised trial 1 5 2 1 4 9 6

File Downloads

Views

Top Country Views

Views
United States 52
Australia 16
China 12
Netherlands 8
Singapore 7
France 6
Vietnam 5
Argentina 3
India 2
Brazil 1

Top City Views

Views
Ashburn 27
Kaleen 13
Rotterdam 8
Fairfield 7
Hanoi 5
Singapore 5
Cambridge 4
Boardman 1
Buffalo 1
Chengdu 1